WP 6 –‘Identification and drivers to aberrant T- and B-cell immunology’ longs to improve the scientific understanding about the role and function of the immune cells that are characteristic for the inflammatory reactions in RA. This will be achieved through a detailed and systematic dissection of the molecular and cellular components of the immune reactions in RA. Studies using biological samples from RA patients will contribute to define candidate molecules, cells and mechanism for validation as therapeutic targets with our industrial partners.
Academic WP-leader: Andrew Cope
EFPIA WP-leader: Jens Gammeltoft Gerwin